Latest Andreas Schreiner News
Apr 6, 2021
During the 60-minute webinar, Andreas Schreiner, MD, Vice President, Medical Affairs Neuroscience and Analgesia; and Hanna Wide, MS, Executive Director, Cell and Gene Therapy, will discuss alternate gene therapies such as opto- and chemogenetics and novel genome-editing technology as well as the use of engineered, non-replicating viral vectors, predominantly recombinant adeno-associated virus or lentivirus. Attendees will learn how to meet the requirements for surgical techniques and equipment when performing intra-CNS administration of viral vectors and operational considerations for Parkinson’s disease gene therapy studies, according to a media release from Xtalks. The free webinar will take place Wednesday, April 14, 2021 at 11am EDT (4pm BST/UK). For more information and to register, visit Xtalks .